var data={"title":"Dextromethorphan abuse and poisoning: Clinical features and diagnosis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Dextromethorphan abuse and poisoning: Clinical features and diagnosis</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Chris Rosenbaum, MD, MSc, FACEP</a></dd><dd><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Edward W Boyer, MD, PhD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Michele M Burns, MD, MPH</a></dd><dd><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Stephen J Traub, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">James F Wiley, II, MD, MPH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;May 12, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The epidemiology, pertinent pharmacology, and clinical features of <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> poisoning will be reviewed here. The treatment of dextromethorphan poisoning is discussed separately. (See <a href=\"topic.htm?path=dextromethorphan-poisoning-treatment\" class=\"medical medical_review\">&quot;Dextromethorphan poisoning: Treatment&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Approximately one million United States youth and young adults (age 12 to 25 years) misuse over-the-counter (OTC) cough and cold medicines that contain <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> each year [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>]. Nonmedical use of dextromethorphan (DXM) results in approximately 6000 emergency department (ED) visits annually in the United States [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/2\" class=\"abstract_t\">2</a>]. Adolescents (age 12 to 20 years) account for almost 50 percent of ED visits. Coingestion of ethanol is frequently seen. Reports from other countries suggest that DXM abuse is prevalent outside of the United States as well [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/3,4\" class=\"abstract_t\">3,4</a>].</p><p>Initially introduced in tablet form during the late 1950s as the OTC cough suppressant Romilar, DXM has a long history of abuse. Because of diversion to recreational use, Romilar was removed from the OTC market in 1973 [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/5,6\" class=\"abstract_t\">5,6</a>]. Subsequently, pharmaceutical companies introduced liquid formulations that were designed to reduce abuse by creating an unpleasant taste if ingested in large amounts [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/6\" class=\"abstract_t\">6</a>]. Before geltabs became more widely available, it took approximately one bottle of cough syrup to achieve a euphoric effect [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/7\" class=\"abstract_t\">7</a>].</p><p>DXM abuse is known as &quot;going pharming,&quot; &quot;Dexing,&quot; &quot;Robodosing,&quot; or &quot;Robotripping&quot; among adolescent and adult users [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/8-10\" class=\"abstract_t\">8-10</a>]. Myriad slang terms exist for DXM based upon tablet appearance and their similarities with popular candies (<a href=\"image.htm?imageKey=EM%2F66199\" class=\"graphic graphic_table graphicRef66199 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/8,9\" class=\"abstract_t\">8,9</a>].</p><p>In 2006, Coricidin, Nyquil, and Robitussin formulations accounted for almost 66 percent of reported instances of <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> misuse among United States persons between the ages of 12 to 25 years [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>]. These cough medicines often combine DXM with <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a>, antihistamines, or decongestants [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/7,8,11-15\" class=\"abstract_t\">7,8,11-15</a>]. In order to extract DXM from unwanted products in combination cold preparations, abusers sometimes perform a two-phase acid base extraction technique using common household products (&quot;Agent Lemon&quot; technique) [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/16\" class=\"abstract_t\">16</a>]. This technique was applied quantitatively to 295 mL of a combination cough and flu medication and found to markedly reduce the amount of acetaminophen and <a href=\"topic.htm?path=pseudoephedrine-drug-information\" class=\"drug drug_general\">pseudoephedrine</a> in the final product while yielding significant quantities of dextromethorphan and <a href=\"topic.htm?path=doxylamine-drug-information\" class=\"drug drug_general\">doxylamine</a> [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/17\" class=\"abstract_t\">17</a>]. Some DXM abusers prefer a single phase acid base extraction technique that results in a substance known as &quot;Crystal Dex&quot; [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/16\" class=\"abstract_t\">16</a>].</p><p>DXM may encourage initiation and progression of substance abuse in teenagers [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/18\" class=\"abstract_t\">18</a>]. Some younger adolescents consider DXM to be a harmless and legal high [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/19\" class=\"abstract_t\">19</a>]. Because it is easily available and produces an intense effect, DXM may entice young users to experience broader and illicit substance abuse experiences [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/19\" class=\"abstract_t\">19</a>]. For example, among young adults who ever misused <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a>, 82, 49, and 44 percent reported use of marijuana, inhalants, or hallucinogens (eg, lysergic acid diethylamide [LSD], phencyclidine [PCP], 3,4-methylenedioxymethamphetamine [ecstasy, MDMA]), respectively [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">PHARMACOLOGY AND CELLULAR TOXICOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">Dextromethorphan</a> (DXM) is the D- isomer of the <a href=\"topic.htm?path=codeine-drug-information\" class=\"drug drug_general\">codeine</a> synthetic analog, <a href=\"topic.htm?path=levorphanol-drug-information\" class=\"drug drug_general\">levorphanol</a>. DXM also contains an alkylated amine adjacent to a cyclohexane ring, a chemical structure that is seen in other dissociative agents (eg, <a href=\"topic.htm?path=ketamine-drug-information\" class=\"drug drug_general\">ketamine</a>, phencyclidine [PCP]). (See <a href=\"topic.htm?path=ketamine-poisoning\" class=\"medical medical_review\">&quot;Ketamine poisoning&quot;</a> and <a href=\"topic.htm?path=phencyclidine-pcp-intoxication-in-children-and-adolescents\" class=\"medical medical_review\">&quot;Phencyclidine (PCP) intoxication in children and adolescents&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Indications</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">Dextromethorphan</a> (DXM) is marketed as a nonsedating and nonaddictive cough suppressant.</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Formulation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are over 140 products that contain <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> (DXM) available worldwide, including:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Combination cough syrups (concentration range 5 to 40 mg per 5 mL, often combined with antihistamine, <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a>, <a href=\"topic.htm?path=guaifenesin-drug-information\" class=\"drug drug_general\">guaifenesin</a> <span class=\"nowrap\">and/or</span> <a href=\"topic.htm?path=pseudoephedrine-drug-information\" class=\"drug drug_general\">pseudoephedrine</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Sustained release cough syrup suspensions (eg, Delsym, 30 mg per 5 mL)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Liquid filled capsules (15, 30 mg)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Oral strips (7.5, 15 mg)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lozenges (5, 7.5, 10 mg)</p><p/><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Toxic dose</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">Dextromethorphan</a> (DXM) toxicity occurs in a dose dependent fashion. Neurobehavioral effects typically begin 30 to 60 minutes post-ingestion and persist for up to six hours [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/20\" class=\"abstract_t\">20</a>]. The different stages of effect are often referred to as &quot;plateaus&quot; by users [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/21,22\" class=\"abstract_t\">21,22</a>], and are listed below along with the approximate range of doses associated with them:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mild stimulation (first &quot;plateau&quot;): 1.5 <span class=\"nowrap\">mg/kg</span> (adult dose: 100 to 200 mg)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Euphoria and hallucinations (second &quot;plateau&quot;): 2.5 to 7.5 <span class=\"nowrap\">mg/kg</span> (adult dose: 200 to 400 mg)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Dissociative &quot;out of body&quot; state (third &quot;plateau&quot;): 7.5 to 15 <span class=\"nowrap\">mg/kg</span> (adult dose: 300 to 600 mg)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Complete dissociation with unresponsiveness (fourth &quot;plateau&quot;): 15 <span class=\"nowrap\">mg/kg</span> (adult dose: &gt;600 mg)</p><p/><p>DXM may produce a life-threatening serotonin syndrome when coingested with monoamine oxidase inhibitors or other serotonergic agents (eg, serotonin specific reuptake inhibitors, <a href=\"topic.htm?path=meperidine-pethidine-drug-information\" class=\"drug drug_general\">meperidine</a>, cocaine) (<a href=\"image.htm?imageKey=EM%2F64604\" class=\"graphic graphic_table graphicRef64604 \">table 2</a>), even in a regular daily dose. (See <a href=\"topic.htm?path=serotonin-syndrome-serotonin-toxicity\" class=\"medical medical_review\">&quot;Serotonin syndrome (serotonin toxicity)&quot;</a>.)</p><p>DXM cough and cold products frequently contain <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a>, antihistamines, or <a href=\"topic.htm?path=pseudoephedrine-drug-information\" class=\"drug drug_general\">pseudoephedrine</a> that has significant toxic potential as well. (See <a href=\"#H16199575\" class=\"local\">'Coingestant findings'</a> below and <a href=\"topic.htm?path=management-of-acetaminophen-paracetamol-poisoning-in-children-and-adolescents\" class=\"medical medical_review\">&quot;Management of acetaminophen (paracetamol) poisoning in children and adolescents&quot;</a> and <a href=\"topic.htm?path=anticholinergic-poisoning\" class=\"medical medical_review\">&quot;Anticholinergic poisoning&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Mechanism of action</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In regular daily dosing, DXM's antitussive effect derives from the binding of sigma opioid receptors in the medulla by the active metabolite, dextrorphan. Because of its stereochemistry, DXM and its metabolites do not bind the mu and delta opioid receptors, thus avoiding classic opioid toxicity [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/23\" class=\"abstract_t\">23</a>]. Dextrorphan also has serotonergic activity at the 5-hydroxytryptophan 2 receptor which explains why a regular dose of DXM can cause serotonin syndrome, especially when coingested with other serotonin agonists (eg, monoamine oxidase inhibitors) [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/24-26\" class=\"abstract_t\">24-26</a>]. (See <a href=\"topic.htm?path=serotonin-syndrome-serotonin-toxicity\" class=\"medical medical_review\">&quot;Serotonin syndrome (serotonin toxicity)&quot;</a>.)</p><p>In overdose, the active metabolite, dextrorphan, inhibits N-methyl-d-aspartate (NMDA) receptors. This action results in neurobehavioral effects similar to <a href=\"topic.htm?path=ketamine-drug-information\" class=\"drug drug_general\">ketamine</a> and phencyclidine (PCP) including hallucinations, &quot;out of body&quot; sensation, and dissociation. DXM also inhibits adrenergic neurotransmitter reuptake in the peripheral and central nervous system resulting in tachycardia, hypertension, and diaphoresis [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/18,27-29\" class=\"abstract_t\">18,27-29</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h1\">KINETICS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pharmacokinetics of <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> (DXM) are as follows [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/18,23,30-33\" class=\"abstract_t\">18,23,30-33</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>DXM is well absorbed with peak serum concentration occurring 2.5 hours after oral ingestion of a regular dose [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/18\" class=\"abstract_t\">18</a>]. Volume of distribution is estimated at 5 to 6.7 <span class=\"nowrap\">L/kg</span>.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>DXM undergoes metabolism in the liver via cytochrome CYP2D6 to dextrorphan (primary active metabolite) and 3-methoxymorphinan [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/18,31,33\" class=\"abstract_t\">18,31,33</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Peak plasma concentration of the active metabolite, dextrorphan, is achieved at 1.6 hours.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Average half-life of the parent compound in therapeutic use is approximately three hours in individuals who are rapid metabolizers and 30 hours in slow metabolizers [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/34\" class=\"abstract_t\">34</a>]. <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">Dextromethorphan</a> and its metabolites, dextrorphan and 3-methoxymorphinan, are almost exclusively renally excreted [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/32\" class=\"abstract_t\">32</a>].</p><p/><p>The neurobehavioral effects of <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> are primarily mediated by the action of the metabolite, dextrorphan at the N-methyl-d-aspartate (NMDA) receptor. Individual response to DXM ingestion is strongly affected by the genetically determined activity of the CYP2D6 enzyme. Approximately 85 percent of the US population have high CYP2D6 activity and would be expected to rapidly develop high dextrorphan levels after overdose. Medications that inhibit cytochrome CYP2D6 (eg, monoamine oxidase inhibitors, <a href=\"topic.htm?path=fluoxetine-drug-information\" class=\"drug drug_general\">fluoxetine</a>, <a href=\"topic.htm?path=paroxetine-drug-information\" class=\"drug drug_general\">paroxetine</a>, and <a href=\"topic.htm?path=haloperidol-drug-information\" class=\"drug drug_general\">haloperidol</a>) increase dextromethorphan levels, decrease dextrorphan levels, and thus dampen the associated neurobehavioral effects [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/23\" class=\"abstract_t\">23</a>]. (See <a href=\"#H7\" class=\"local\">'Mechanism of action'</a> above.)</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">CLINICAL FEATURES</span></p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">History</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Historical features of <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> poisoning vary significantly by age.</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h3\">Youth and adults</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">Dextromethorphan</a> misuse is most frequent in adolescents and young adults [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/1\" class=\"abstract_t\">1</a>]. These patients often arrive in the emergency department (ED) with altered mental status and may not provide a history. Witnesses of the ingestion or emergency medical services (EMS) personnel, who may have recovered containers at the scene, should be interviewed in this setting. Key information includes the specific dextromethorphan containing substance, amount ingested, time of ingestion, and coingestion of ethanol, serotonergic agents (especially ecstasy [3,4-methylenedioxymethamphetamine]), or other recreational drugs.</p><p>Additional history should identify the likelihood of trauma (particularly head trauma) and rape. Often, EMS reports regarding the environment in which the patient was found and whether the patient was partially or fully undressed can assist in identifying physical or sexual assault.</p><p>Up to 14 percent of <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> overdoses in teenagers and young adults seen in the emergency department are part of a suicide attempt [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/2\" class=\"abstract_t\">2</a>]. Thus, direct questioning regarding suicidal intent should occur in all intentional dextromethorphan ingestions. If suicidal ideation is present, further mental health evaluation is indicated after the patient recovers from the intoxication.</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h3\">Children</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Infants and young children intoxicated by <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a>, may also present with an intercurrent viral illness and sudden change in behavior. Fever is variably present. The caretaker should be carefully questioned about the use of over-the-counter (OTC) medications including the exact name of the medication, the amount of medication being given, and the frequency of dosing. Although OTC cough and cold medications intended for use in children under two years of age have been removed from the United States market, caregivers may still have supplies at home or may give liquid formulations intended for older children.</p><p>Exploratory ingestions of OTC cough and cold medications occur frequently in young children. As a general rule, ingestion of an amount that is less than the estimated total daily dose for the child does not produce significant toxicity other than self-limited lethargy [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/35\" class=\"abstract_t\">35</a>]. In this circumstance, caretakers should also be questioned regarding other medications in the house and asked to check the home for signs of other toxic exposures. The patient's or caretaker's pharmacy may provide valuable information regarding prescribed medications available for ingestion, the date of the most recent refill, and the total number of pills dispensed. (See <a href=\"topic.htm?path=over-the-counter-cough-and-cold-preparations-approach-to-pediatric-poisoning#H14696055\" class=\"medical medical_review\">&quot;Over-the-counter cough and cold preparations: Approach to pediatric poisoning&quot;, section on 'Dextromethorphan'</a>.)</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Physical examination</span></p><p class=\"headingAnchor\" id=\"H16200405\"><span class=\"h3\">Acute overdose</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Following acute overdose <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> produces several characteristic physical findings that may be variably present depending on the dose ingested [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/7,8,21,28,29,36\" class=\"abstract_t\">7,8,21,28,29,36</a>] (see <a href=\"#H6\" class=\"local\">'Toxic dose'</a> above):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Neurobehavioral changes that include euphoria, hallucinations, inappropriate laughing, psychosis with dissociative features, agitation, and coma</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Tachycardia</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Dilated pupils</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Diaphoresis (in the absence of anticholinergic coingestion)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>&quot;Zombie-like&quot; ataxic gait</p><p/><p>Tachycardia is such a consistent finding that its absence should call in to question the diagnosis of <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> intoxication unless the patient is also taking another agent (eg, beta-blocker, calcium channel blocker, <a href=\"topic.htm?path=digoxin-drug-information\" class=\"drug drug_general\">digoxin</a>) that would prevent tachycardia.</p><p>Agitation in association with severe <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> intoxication may also result in hyperthermia and metabolic acidosis with potential for rhabdomyolysis [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/7,8,21,28,29\" class=\"abstract_t\">7,8,21,28,29</a>].</p><p><a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">Dextromethorphan</a> may precipitate serotonin syndrome (altered mental status, seizures, autonomic instability, <span class=\"nowrap\">and/or</span> muscular hypertonicity) in overdose and when combined with monoamine oxidase inhibitors, serotonin specific reuptake inhibitors, <a href=\"topic.htm?path=linezolid-drug-information\" class=\"drug drug_general\">linezolid</a>, <a href=\"topic.htm?path=meperidine-pethidine-drug-information\" class=\"drug drug_general\">meperidine</a>, <a href=\"topic.htm?path=tramadol-drug-information\" class=\"drug drug_general\">tramadol</a>, and other serotonergic agents [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/25,37\" class=\"abstract_t\">25,37</a>]. (See <a href=\"topic.htm?path=serotonin-syndrome-serotonin-toxicity\" class=\"medical medical_review\">&quot;Serotonin syndrome (serotonin toxicity)&quot;</a>.)</p><p>Nystagmus is sometimes seen, but this finding may also indicate serotonin syndrome, ethanol intoxication, anticonvulsant overdose, <a href=\"topic.htm?path=ketamine-drug-information\" class=\"drug drug_general\">ketamine</a> toxicity, or PCP exposure.</p><p>Respiratory depression and apnea have occurred in infants and young children [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/38,39\" class=\"abstract_t\">38,39</a>]. Dystonia responsive to <a href=\"topic.htm?path=diphenhydramine-drug-information\" class=\"drug drug_general\">diphenhydramine</a> has also been described [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/29,36\" class=\"abstract_t\">29,36</a>].</p><p class=\"headingAnchor\" id=\"H16199575\"><span class=\"h3\">Coingestant findings</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In addition to <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a>, over-the-counter cough formulations frequently contain other pharmaceutical agents such as <a href=\"topic.htm?path=chlorpheniramine-drug-information\" class=\"drug drug_general\">chlorpheniramine</a> or other antihistamines, <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a>, or <a href=\"topic.htm?path=pseudoephedrine-drug-information\" class=\"drug drug_general\">pseudoephedrine</a> whose toxicity may complicate dextromethorphan poisoning [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/40\" class=\"abstract_t\">40</a>] (<a href=\"image.htm?imageKey=EM%2F94240\" class=\"graphic graphic_table graphicRef94240 \">table 3</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Coingestion of antihistamines with high H1-receptor antagonist properties (eg, <a href=\"topic.htm?path=chlorpheniramine-drug-information\" class=\"drug drug_general\">chlorpheniramine</a>) can cause features of anticholinergic poisoning such as tachycardia, hypertension, hyperthermia, flushing, warm and dry skin, sluggishly reactive pupils, and agitated delirium (<a href=\"image.htm?imageKey=EM%2F71268\" class=\"graphic graphic_table graphicRef71268 \">table 4</a>). Rarely, seizures and rhabdomyolysis may occur [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/8\" class=\"abstract_t\">8</a>]. (See <a href=\"topic.htm?path=anticholinergic-poisoning\" class=\"medical medical_review\">&quot;Anticholinergic poisoning&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Alpha1 adrenergic agonist decongestants (eg, <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a> or <a href=\"topic.htm?path=pseudoephedrine-drug-information\" class=\"drug drug_general\">pseudoephedrine</a>), typically causes tachycardia or reflex bradycardia with hypertension. Headache, agitation, and hypertensive emergency may develop in patients with severe toxicity. (See <a href=\"topic.htm?path=phenylephrine-and-related-decongestants-pediatric-poisoning#H3737806\" class=\"medical medical_review\">&quot;Phenylephrine and related decongestants: Pediatric poisoning&quot;, section on 'Clinical features and diagnosis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">Acetaminophen</a> is commonly present in cough and cold preparations. Although it rarely causes immediate symptoms, acetaminophen has high potential to cause severe delayed hepatotoxicity, hepatic failure, and death. It is imperative for the emergency provider to obtain an acetaminophen level in all patients with serious <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> exposure in order to detect this threat. (See <a href=\"topic.htm?path=management-of-acetaminophen-paracetamol-poisoning-in-children-and-adolescents\" class=\"medical medical_review\">&quot;Management of acetaminophen (paracetamol) poisoning in children and adolescents&quot;</a> and <a href=\"topic.htm?path=acetaminophen-paracetamol-poisoning-in-adults-pathophysiology-presentation-and-diagnosis\" class=\"medical medical_review\">&quot;Acetaminophen (paracetamol) poisoning in adults: Pathophysiology, presentation, and diagnosis&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H16200151\"><span class=\"h3\">Signs of chronic use</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A rapidly progressive tolerance is frequently described by experienced <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> users [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/6,21,41,42\" class=\"abstract_t\">6,21,41,42</a>]. Repeated dextromethorphan use has also been associated with toxic psychosis and cognitive deterioration [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/41,43,44\" class=\"abstract_t\">41,43,44</a>]. In addition, habitual use and craving may occur in susceptible individuals [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/7,45\" class=\"abstract_t\">7,45</a>]. Abrupt cessation of dextromethorphan in these patients may result in dysphoria and intense craving [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/41-44\" class=\"abstract_t\">41-44</a>].</p><p>Because <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> is produced as the crystalline hydrobromide salt, bromism marked by fatigue, ataxia, headache, and memory loss is a rare consequence that has also been observed in heavy chronic abusers of dextromethorphan [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/46\" class=\"abstract_t\">46</a>]. A negative anion gap or elevated chloride concentration on serum laboratory testing should raise the concern for bromism [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/47\" class=\"abstract_t\">47</a>].</p><p class=\"headingAnchor\" id=\"H24717497\"><span class=\"h2\">Ancillary studies</span></p><p class=\"headingAnchor\" id=\"H24717633\"><span class=\"h3\">Acetaminophen level</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A serum <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a> level should be obtained in all patients with <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> exposure, including asymptomatic patients, unless coingestion of acetaminophen can be reliably excluded. Serum acetaminophen should also be obtained in patients who ingested dextromethorphan with suicidal intent.</p><p>The serum <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a> concentration should be measured between 4 and 24 hours after a single acute overdose of an immediate-release preparation and plotted on the modified Rumack-Matthew nomogram (<a href=\"image.htm?imageKey=EM%2F83590\" class=\"graphic graphic_figure graphicRef83590 \">figure 1</a>) to determine the need for antidotal therapy with N-acetylcysteine. (See <a href=\"topic.htm?path=acetaminophen-paracetamol-poisoning-in-adults-pathophysiology-presentation-and-diagnosis#H24\" class=\"medical medical_review\">&quot;Acetaminophen (paracetamol) poisoning in adults: Pathophysiology, presentation, and diagnosis&quot;, section on 'General approach and serum acetaminophen concentration'</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acetaminophen-paracetamol-poisoning-in-children-and-adolescents#H5085042\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of acetaminophen (paracetamol) poisoning in children and adolescents&quot;, section on 'Acetaminophen level'</a>.)</p><p class=\"headingAnchor\" id=\"H24717639\"><span class=\"h3\">Other studies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Further laboratory evaluation of <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> intoxication varies depending on the clinical findings. Other ancillary studies may be indicated in selected patients in whom ingestion of other toxic agents, trauma, or sexual assault are suspected. (See <a href=\"topic.htm?path=evaluation-of-stupor-and-coma-in-children\" class=\"medical medical_review\">&quot;Evaluation of stupor and coma in children&quot;</a> and <a href=\"topic.htm?path=approach-to-the-child-with-occult-toxic-exposure\" class=\"medical medical_review\">&quot;Approach to the child with occult toxic exposure&quot;</a> and <a href=\"topic.htm?path=trauma-management-approach-to-the-unstable-child\" class=\"medical medical_review\">&quot;Trauma management: Approach to the unstable child&quot;</a> and <a href=\"topic.htm?path=evaluation-and-management-of-adult-and-adolescent-sexual-assault-victims\" class=\"medical medical_review\">&quot;Evaluation and management of adult and adolescent sexual assault victims&quot;</a> and <a href=\"topic.htm?path=testing-for-drugs-of-abuse-doa#H4849010\" class=\"medical medical_review\">&quot;Testing for drugs of abuse (DOA)&quot;, section on 'Sexual assault (date rape)'</a>.)</p><p>We suggest the following tests in patients with altered mental function and suspected <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> overdose:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Bedside glucose determination, to exclude hypoglycemia as the cause of altered consciousness.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Arterial or venous blood gas measurement and continuous pulse oximetry to evaluate the adequacy of ventilation in patients with serious and persistent central nervous system depression.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Serum electrolyte determination to assess for electrolyte disturbance and to calculate the anion gap in the setting of likely coingestants or evidence for metabolic acidosis. A negative anion gap or elevated chloride concentration should prompt a consideration for possible bromism [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/47\" class=\"abstract_t\">47</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Serum blood urea nitrogen and creatinine to identify patients with renal insufficiency who may have delayed elimination of <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> and its metabolites after overdose.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Liver enzyme studies (Aspartate transferase [AST], Alanine transferase [ALT]), prothrombin time (PT), and partial thromboplastin time (PTT) to determine presence of liver injury and as baseline values in patients with possible <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a> overdose.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Serum creatine phosphokinase in patients with agitation, seizures, or likely serotonin syndrome to diagnose rhabdomyolysis. Urine tests that are supportive but not diagnostic for rhabdomyolysis include reddish brown discoloration, rapid urine dipstick that is positive for heme, and the presence of urine myoglobin. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-rhabdomyolysis#H25330957\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of rhabdomyolysis&quot;, section on 'Clinical manifestations'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Serum ethanol level, to identify patients at a higher risk for coma with respiratory depression due to coingestion of <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> and ethanol.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A plasma salicylate level, especially in patients with altered mental status, tachypnea, tachycardia, vomiting, or evidence for an anion gap metabolic acidosis. (See <a href=\"topic.htm?path=salicylate-aspirin-poisoning-in-adults\" class=\"medical medical_review\">&quot;Salicylate (aspirin) poisoning in adults&quot;</a> and <a href=\"topic.htm?path=salicylate-poisoning-in-children-and-adolescents\" class=\"medical medical_review\">&quot;Salicylate poisoning in children and adolescents&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Rapid urine toxicology screen for drugs of abuse.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Rapid urine pregnancy test in postmenarchal women.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Electrocardiogram (EKG), to evaluate for drug-induced cardiac electrical dysfunction (especially sodium channel blockade [eg, prolonged QRS complex <span class=\"nowrap\">and/or</span> significant R wave in lead aVR] or QTc prolongation) [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/48\" class=\"abstract_t\">48</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chest radiography, if the history or exam suggests the possibility of pulmonary aspiration.</p><p/><p class=\"headingAnchor\" id=\"H16199387\"><span class=\"h3\">Dextromethorphan testing</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">Dextromethorphan</a> poisoning is usually diagnosed based on history and clinical findings. Commonly available drugs of abuse rapid urine screens rely on immunoassay techniques that do not detect dextromethorphan [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/18\" class=\"abstract_t\">18</a>]. However, dextromethorphan will frequently cause a false positive for phencyclidine (PCP) on rapid tests that utilize liquid chromatography [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/49-51\" class=\"abstract_t\">49-51</a>].</p><p>Quantitative and qualitative testing for <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> is available from dedicated toxicology reference laboratories with methodology such as gas chromatography or mass spectroscopy. However, the results usually cannot be obtained in time to be useful for patient management. Thus, specific measurement of dextromethorphan in the blood or other fluids is typically performed only for forensic or other nonclinical purposes.</p><p class=\"headingAnchor\" id=\"H24717885\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">Dextromethorphan</a> poisoning is a clinical diagnosis. The emergency provider should suspect dextromethorphan ingestion in youth, young adults, and adults who have abrupt change in behavior associated with hallucinations, gait disturbance, and clinical findings of sympathetic stimulation (dilated pupils, tachycardia, and diaphoresis). Infants and young children may have an acute onset of altered mental status ranging from coma to irritability.</p><p>The clinical diagnosis of <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> poisoning may also be supported by a false positive for phencyclidine (PCP) on rapid tests that utilize liquid chromatography. Quantitative and qualitative testing for dextromethorphan is available, but is not usually performed for diagnostic purposes. (See <a href=\"#H16199387\" class=\"local\">'Dextromethorphan testing'</a> above.)</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are many causes of neurobehavioral changes with psychotic features that deserve consideration when evaluating the patient with suspected <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> poisoning (<a href=\"image.htm?imageKey=EM%2F52785\" class=\"graphic graphic_table graphicRef52785 \">table 5</a> and <a href=\"image.htm?imageKey=EM%2F50275\" class=\"graphic graphic_table graphicRef50275 \">table 6</a>). In the poisoned patient, it is especially important to consider hypoglycemia and potential traumatic brain injury. The approach to acute onset psychosis in children is discussed in detail separately. (See <a href=\"topic.htm?path=emergency-department-evaluation-of-acute-onset-psychosis-in-children\" class=\"medical medical_review\">&quot;Emergency department evaluation of acute onset psychosis in children&quot;</a>.)</p><p>Toxicologic causes of ataxia, nystagmus, and mental status changes include ethanol (a common coingestant with <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a>), <a href=\"topic.htm?path=ketamine-drug-information\" class=\"drug drug_general\">ketamine</a>, phencyclidine (PCP), <a href=\"topic.htm?path=lithium-drug-information\" class=\"drug drug_general\">lithium</a>, <a href=\"topic.htm?path=phenytoin-drug-information\" class=\"drug drug_general\">phenytoin</a>, or <a href=\"topic.htm?path=carbamazepine-drug-information\" class=\"drug drug_general\">carbamazepine</a>. The clinical findings after overdose of these agents may be very similar. The specific agent causing toxicity can be identified by history; blood levels of ethanol, lithium, phenytoin, and carbamazepine; and rapid urine testing for PCP. (See <a href=\"topic.htm?path=ethanol-intoxication-in-children-clinical-features-evaluation-and-management\" class=\"medical medical_review\">&quot;Ethanol intoxication in children: Clinical features, evaluation, and management&quot;</a> and <a href=\"topic.htm?path=ethanol-intoxication-in-adults\" class=\"medical medical_review\">&quot;Ethanol intoxication in adults&quot;</a> and <a href=\"topic.htm?path=phencyclidine-pcp-intoxication-in-children-and-adolescents\" class=\"medical medical_review\">&quot;Phencyclidine (PCP) intoxication in children and adolescents&quot;</a> and <a href=\"topic.htm?path=phencyclidine-pcp-intoxication-in-adults\" class=\"medical medical_review\">&quot;Phencyclidine (PCP) intoxication in adults&quot;</a> and <a href=\"topic.htm?path=intoxication-from-lsd-and-other-common-hallucinogens\" class=\"medical medical_review\">&quot;Intoxication from LSD and other common hallucinogens&quot;</a> and <a href=\"topic.htm?path=ketamine-poisoning\" class=\"medical medical_review\">&quot;Ketamine poisoning&quot;</a> and <a href=\"topic.htm?path=lithium-poisoning\" class=\"medical medical_review\">&quot;Lithium poisoning&quot;</a> and <a href=\"topic.htm?path=carbamazepine-poisoning\" class=\"medical medical_review\">&quot;Carbamazepine poisoning&quot;</a> and <a href=\"topic.htm?path=phenytoin-poisoning\" class=\"medical medical_review\">&quot;Phenytoin poisoning&quot;</a>.)</p><p>Wernicke-Korsakoff syndrome, serotonin syndrome from agents other than <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a>, and abstinence syndromes (eg, ethanol withdrawal) have findings that overlap significantly with dextromethorphan toxicity, but are more commonly seen in adults [<a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/6\" class=\"abstract_t\">6</a>]. A history of alcoholism or ingestion of another serotonergic agent is essential to recognize these conditions. (See <a href=\"topic.htm?path=wernicke-encephalopathy#H6\" class=\"medical medical_review\">&quot;Wernicke encephalopathy&quot;, section on 'Clinical manifestations'</a> and <a href=\"topic.htm?path=management-of-moderate-and-severe-alcohol-withdrawal-syndromes#H9\" class=\"medical medical_review\">&quot;Management of moderate and severe alcohol withdrawal syndromes&quot;, section on 'Delirium tremens (DT)'</a> and <a href=\"topic.htm?path=serotonin-syndrome-serotonin-toxicity#H4\" class=\"medical medical_review\">&quot;Serotonin syndrome (serotonin toxicity)&quot;, section on 'Clinical features'</a>.)</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h1\">ADDITIONAL RESOURCES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Regional poison control centers in the United States are available at all times for consultation on patients who are critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have clinical <span class=\"nowrap\">and/or</span> medical toxicologists available for bedside consultation <span class=\"nowrap\">and/or</span> inpatient care. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. The World Health Organization provides a listing of international poison centers at its <a href=\"http://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html&amp;token=vYXClxsD0hnrf4M8kYcoD1kMICrGjKQRRaFc8pA0pw9qlhpVmsmYh2e3Gi7webw9H9uSzH3nipQ0rPpTLYBWhGP+/wpQqUegRzvggwgKA6s=&amp;TOPIC_ID=6488\" target=\"_blank\" class=\"external\">website</a>.</p><p class=\"headingAnchor\" id=\"H275830261\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-general-measures-for-acute-poisoning-treatment\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: General measures for acute poisoning treatment&quot;</a> and <a href=\"topic.htm?path=society-guideline-links-treatment-of-acute-poisoning-caused-by-specific-agents-other-than-drugs-of-abuse\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Treatment of acute poisoning caused by specific agents other than drugs of abuse&quot;</a>.) </p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">Dextromethorphan</a> (d-3-methoxy-N-methylmorphinan, DXM) is an over-the-counter (OTC) cough suppressant that is commonly diverted for illicit recreational use among teenagers and young adults. While structurally related to the opiate receptor agonist <a href=\"topic.htm?path=codeine-drug-information\" class=\"drug drug_general\">codeine</a>, DXM in overdose expresses a unique combination of euphoric, stimulant, and dissociative effects in older children and adolescents that is similar to <a href=\"topic.htm?path=ketamine-drug-information\" class=\"drug drug_general\">ketamine</a> and phencyclidine (PCP). (See <a href=\"#H2\" class=\"local\">'Epidemiology'</a> above and <a href=\"#H3\" class=\"local\">'Pharmacology and cellular toxicology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">Dextromethorphan</a> (DXM) toxicity occurs in a dose dependent fashion. Neurobehavioral effects typically begin 30 to 60 minutes after ingestion and persist for up to six hours. (See <a href=\"#H6\" class=\"local\">'Toxic dose'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In infants and children, <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> poisoning may follow excessive dosing by a caregiver in attempts to treat an upper respiratory illness. Exploratory ingestions in young children and infants usually have minimal symptoms but have the potential to cause marked respiratory depression and apnea. (See <a href=\"#H12\" class=\"local\">'Children'</a> above and <a href=\"#H13\" class=\"local\">'Physical examination'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Prominent clinical findings of DXM overdose in teenagers and adults consist of neurobehavioral changes (eg, euphoria, hallucinations, inappropriate laughing, psychosis with dissociative features, agitation, and coma), tachycardia, dilated pupils, diaphoresis, and &quot;zombie-like&quot; ataxic gait. (See <a href=\"#H6\" class=\"local\">'Toxic dose'</a> above and <a href=\"#H9\" class=\"local\">'Clinical features'</a> above and <a href=\"#H13\" class=\"local\">'Physical examination'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">Dextromethorphan</a> may also precipitate serotonin syndrome (altered mental status, seizures, autonomic instability, and muscular hypertonicity) alone in overdose and in regular daily dosing when inappropriately combined with monoamine oxidase inhibitors, serotonin specific reuptake inhibitors, <a href=\"topic.htm?path=linezolid-drug-information\" class=\"drug drug_general\">linezolid</a>, <a href=\"topic.htm?path=meperidine-pethidine-drug-information\" class=\"drug drug_general\">meperidine</a>, <a href=\"topic.htm?path=tramadol-drug-information\" class=\"drug drug_general\">tramadol</a>, and other serotonergic agents (<a href=\"image.htm?imageKey=EM%2F64604\" class=\"graphic graphic_table graphicRef64604 \">table 2</a>). (See <a href=\"topic.htm?path=serotonin-syndrome-serotonin-toxicity\" class=\"medical medical_review\">&quot;Serotonin syndrome (serotonin toxicity)&quot;</a> and <a href=\"#H13\" class=\"local\">'Physical examination'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>With <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> poisoning, additional toxicity derives from the ingestion of other ingredients in common OTC cough and cold medications such as <a href=\"topic.htm?path=acetaminophen-paracetamol-drug-information\" class=\"drug drug_general\">acetaminophen</a>, antihistamines, and decongestants (<a href=\"image.htm?imageKey=EM%2F94240\" class=\"graphic graphic_table graphicRef94240 \">table 3</a>). (See <a href=\"#H5\" class=\"local\">'Formulation'</a> above and <a href=\"#H16199575\" class=\"local\">'Coingestant findings'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Diagnosis of <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> poisoning depends upon recognition of the clinical presentation and exclusion of other causes for acute psychosis, especially hypoglycemia and hypoxia (<a href=\"image.htm?imageKey=EM%2F52785\" class=\"graphic graphic_table graphicRef52785 \">table 5</a> and <a href=\"image.htm?imageKey=EM%2F50275\" class=\"graphic graphic_table graphicRef50275 \">table 6</a>). (See <a href=\"#H24717885\" class=\"local\">'Diagnosis'</a> above and <a href=\"#H16\" class=\"local\">'Differential diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The treatment of <a href=\"topic.htm?path=dextromethorphan-drug-information\" class=\"drug drug_general\">dextromethorphan</a> poisoning is discussed separately. (See <a href=\"topic.htm?path=dextromethorphan-poisoning-treatment\" class=\"medical medical_review\">&quot;Dextromethorphan poisoning: Treatment&quot;</a>.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li class=\"breakAll\">Substance Abuse and Mental Health Services Administration. Office of Applied Studies. The NSDUH report: misuse of over-the-counter cough and cold medications among persons aged 12 to 25. http://www.oas.samhsa.gov/2k8/cough/cough.cfm (Accessed on December 16, 2008).</li><li class=\"breakAll\">Ball JK, Albright V. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Emergency department visits involving dextromethorphan. The New DAWN report 2006; 32:1. http://www.oas.samhsa.gov/DAWN/dextromethorphan.cfm (Accessed on December 16, 2008).</li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/3\" class=\"nounderline abstract_t\">Abanades S, Peir&oacute; AM, Farr&eacute; M. [Club drugs: old medicines as new party drugs]. Med Clin (Barc) 2004; 123:305.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/4\" class=\"nounderline abstract_t\">Chung H, Park M, Hahn E, et al. Recent trends of drug abuse and drug-associated deaths in Korea. Ann N Y Acad Sci 2004; 1025:458.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/5\" class=\"nounderline abstract_t\">Shulgin AT. Drugs of abuse in the future. Clin Toxicol 1975; 8:405.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/6\" class=\"nounderline abstract_t\">Wolfe TR, Caravati EM. Massive dextromethorphan ingestion and abuse. Am J Emerg Med 1995; 13:174.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/7\" class=\"nounderline abstract_t\">Banerji S, Anderson IB. Abuse of Coricidin HBP cough &amp; cold tablets: episodes recorded by a poison center. Am J Health Syst Pharm 2001; 58:1811.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/8\" class=\"nounderline abstract_t\">Kirages TJ, Sul&eacute; HP, Mycyk MB. Severe manifestations of coricidin intoxication. Am J Emerg Med 2003; 21:473.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/9\" class=\"nounderline abstract_t\">Desai S, Aldea D, Daneels E, et al. Chronic addiction to dextromethorphan cough syrup: a case report. J Am Board Fam Med 2006; 19:320.</a></li><li class=\"breakAll\">Department of Health and Human Services. Trouble in the medicine chest (I):Rx drug abuse growing. http://ncadi.samhsa.gov/govpubs/prevalert/v6/4.aspx (Accessed on January 29, 2008).</li><li class=\"breakAll\">Watson, W. Toxic exposure surveillance system dextromethorphan data. American Association of Poison Control Centers, Washington, DC 2003.</li><li class=\"breakAll\">Drug Abuse Warning Network. Emergency department visits involving dextromethorphan, 2006 http://www.oas.samhsa.gov (Accessed on January 29, 2008).</li><li class=\"breakAll\">National Survey on Drug Use and Health. Misuse of Over-the-Counter Cough and Cold Medications among Persons Aged 12 to 25, 2008. http://www.oas.samhsa.gov (Accessed on January 29, 2008).</li><li class=\"breakAll\">Boyer EW. 2003 Poisoning Data: Massachusetts Poison Control Center, 2003.</li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/15\" class=\"nounderline abstract_t\">Simone K, Bottei E, Siegel E, et al. Coricidin abuse in Ohio teens and young adults. J Toxicol Clin Toxicol 2000; 38:532.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/16\" class=\"nounderline abstract_t\">Hendrickson RG, Cloutier RL. &quot;Crystal dex:&quot; free-base dextromethorphan. J Emerg Med 2007; 32:393.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/17\" class=\"nounderline abstract_t\">Hendrickson RG. &quot;DXemon juice:&quot; analytical evaluation of an extraction process for the purification and freebasing of dextromethorphan from cold preparations. J Med Toxicol 2008; 4:309.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/18\" class=\"nounderline abstract_t\">Boyer EW. Dextromethorphan abuse. Pediatr Emerg Care 2004; 20:858.</a></li><li class=\"breakAll\">O'Brien M. Emerging trends in drug use. Community Epidemiology Working Group Annual Conference. National Institutes on Drug Abuse. Atlanta 2003.</li><li class=\"breakAll\">Boyer E. Dissociative agents: Phencyclidine, ketamine, and dextromethorphan. In: Haddad adn Winchester's Clinical Management of Poisoning and Drug Overdose, 4th, Shannon MW, Borron SW, Burns MJ (Eds), Saunders, Philadelphia 2007. p.776.</li><li class=\"breakAll\">White, W. DXM FAQ, 1995. http://www.erowid.org (Accessed on January 29, 2008).</li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/22\" class=\"nounderline abstract_t\">Logan BK, Yeakel JK, Goldfogel G, et al. Dextromethorphan abuse leading to assault, suicide, or homicide. J Forensic Sci 2012; 57:1388.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/23\" class=\"nounderline abstract_t\">Siu A, Drachtman R. Dextromethorphan: a review of N-methyl-d-aspartate receptor antagonist in the management of pain. CNS Drug Rev 2007; 13:96.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/24\" class=\"nounderline abstract_t\">Kim HS, Park IS, Lim HK, Choi HS. NMDA receptor antagonists enhance 5-HT2 receptor-mediated behavior, head-twitch response, in PCPA-treated mice. Arch Pharm Res 1999; 22:113.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/25\" class=\"nounderline abstract_t\">Ganetsky M, Babu KM, Boyer EW. Serotonin syndrome in dextromethorphan ingestion responsive to propofol therapy. Pediatr Emerg Care 2007; 23:829.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/26\" class=\"nounderline abstract_t\">Kamei J, Mori T, Igarashi H, Kasuya Y. Serotonin release in nucleus of the solitary tract and its modulation by antitussive drugs. Res Commun Chem Pathol Pharmacol 1992; 76:371.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/27\" class=\"nounderline abstract_t\">Steinmiller CL, Maisonneuve IM, Glick SD. Effects of dextromethorphan on dopamine release in the nucleus accumbens: Interactions with morphine. Pharmacol Biochem Behav 2003; 74:803.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/28\" class=\"nounderline abstract_t\">Graudins A, Fern RP. Acute dystonia in a child associated with therapeutic ingestion of a dextromethorphan containing cough and cold syrup. J Toxicol Clin Toxicol 1996; 34:351.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/29\" class=\"nounderline abstract_t\">Warden CR, Diekema DS, Robertson WO. Dystonic reaction associated with dextromethorphan ingestion in a toddler. Pediatr Emerg Care 1997; 13:214.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/30\" class=\"nounderline abstract_t\">Barnhart JW, Massad EN. Determination of dextromethorphan in serum by gas chromatography. J Chromatogr 1979; 163:390.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/31\" class=\"nounderline abstract_t\">Silvasti M, Karttunen P, Tukiainen H, et al. Pharmacokinetics of dextromethorphan and dextrorphan: a single dose comparison of three preparations in human volunteers. Int J Clin Pharmacol Ther Toxicol 1987; 25:493.</a></li><li class=\"breakAll\">Baselt R, Cravey R. Disposition of Toxic Drugs and Chemicals in Man, Yearbook, Chicago 1989.</li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/33\" class=\"nounderline abstract_t\">Schadel M, Wu D, Otton SV, et al. Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition. J Clin Psychopharmacol 1995; 15:263.</a></li><li class=\"breakAll\">Pharmacokinetic data. In: Goodman &amp; Gilman's The Pharmacologic Basis of Therapeutics, 11th, Brunton LL, Lazo JS, Parker KL (Eds), McGraw HIll, New York 2006. p.1816.</li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/35\" class=\"nounderline abstract_t\">LoVecchio F, Pizon A, Matesick L, O'Patry S. Accidental dextromethorphan ingestions in children less than 5 years old. J Med Toxicol 2008; 4:251.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/36\" class=\"nounderline abstract_t\">Paul IM, Reynolds KM, Kauffman RE, et al. Adverse events associated with pediatric exposures to dextromethorphan. Clin Toxicol (Phila) 2017; 55:25.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/37\" class=\"nounderline abstract_t\">Bowdle TA. Adverse effects of opioid agonists and agonist-antagonists in anaesthesia. Drug Saf 1998; 19:173.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/38\" class=\"nounderline abstract_t\">Shaul WL, Wandell M, Robertson WO. Dextromethorphan toxicity: reversal by naloxone. Pediatrics 1977; 59:117.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/39\" class=\"nounderline abstract_t\">Henretig FM. Special considerations in the poisoned pediatric patient. Emerg Med Clin North Am 1994; 12:549.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/40\" class=\"nounderline abstract_t\">Helfer J, Kim OM. Psychoactive abuse potential of Robitussin-DM. Am J Psychiatry 1990; 147:672.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/41\" class=\"nounderline abstract_t\">Hinsberger A, Sharma V, Mazmanian D. Cognitive deterioration from long-term abuse of dextromethorphan: a case report. J Psychiatry Neurosci 1994; 19:375.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/42\" class=\"nounderline abstract_t\">Fleming PM. Dependence on dextromethorphan hydrobromide. Br Med J (Clin Res Ed) 1986; 293:597.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/43\" class=\"nounderline abstract_t\">Dodds, A. Toxic psychosis due to dextromethorphan. Med J Aust 1967; 2:231.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/44\" class=\"nounderline abstract_t\">Schadel M, Sellers EM. Psychosis with Vicks Formula 44-D abuse. CMAJ 1992; 147:843.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/45\" class=\"nounderline abstract_t\">Nicholson KL, Hayes BA, Balster RL. Evaluation of the reinforcing properties and phencyclidine-like discriminative stimulus effects of dextromethorphan and dextrorphan in rats and rhesus monkeys. Psychopharmacology (Berl) 1999; 146:49.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/46\" class=\"nounderline abstract_t\">Ng YY, Lin WL, Chen TW, et al. Spurious hyperchloremia and decreased anion gap in a patient with dextromethorphan bromide. Am J Nephrol 1992; 12:268.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/47\" class=\"nounderline abstract_t\">Horowitz BZ. Bromism from excessive cola consumption. J Toxicol Clin Toxicol 1997; 35:315.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/48\" class=\"nounderline abstract_t\">Liebelt EL, Francis PD, Woolf AD. ECG lead aVR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity. Ann Emerg Med 1995; 26:195.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/49\" class=\"nounderline abstract_t\">Darboe MN, Keenan GR Jr, Richards TK. The abuse of dextromethorphan-based cough syrup: a pilot study of the community of Waynesboro, Pennsylvania. Adolescence 1996; 31:633.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/50\" class=\"nounderline abstract_t\">Schier J. Avoid unfavorable consequences: dextromethorpan can bring about a false-positive phencyclidine urine drug screen. J Emerg Med 2000; 18:379.</a></li><li><a href=\"https://www.uptodate.com/contents/dextromethorphan-abuse-and-poisoning-clinical-features-and-diagnosis/abstract/51\" class=\"nounderline abstract_t\">Williams JF, Kokotailo PK. Abuse of proprietary (over-the-counter) drugs. Adolesc Med Clin 2006; 17:733.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 6488 Version 11.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H22\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">PHARMACOLOGY AND CELLULAR TOXICOLOGY</a><ul><li><a href=\"#H4\" id=\"outline-link-H4\">Indications</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Formulation</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">Toxic dose</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">Mechanism of action</a></li></ul></li><li><a href=\"#H8\" id=\"outline-link-H8\">KINETICS</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">CLINICAL FEATURES</a><ul><li><a href=\"#H10\" id=\"outline-link-H10\">History</a><ul><li><a href=\"#H11\" id=\"outline-link-H11\">- Youth and adults</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">- Children</a></li></ul></li><li><a href=\"#H13\" id=\"outline-link-H13\">Physical examination</a><ul><li><a href=\"#H16200405\" id=\"outline-link-H16200405\">- Acute overdose</a></li><li><a href=\"#H16199575\" id=\"outline-link-H16199575\">- Coingestant findings</a></li><li><a href=\"#H16200151\" id=\"outline-link-H16200151\">- Signs of chronic use</a></li></ul></li><li><a href=\"#H24717497\" id=\"outline-link-H24717497\">Ancillary studies</a><ul><li><a href=\"#H24717633\" id=\"outline-link-H24717633\">- Acetaminophen level</a></li><li><a href=\"#H24717639\" id=\"outline-link-H24717639\">- Other studies</a></li><li><a href=\"#H16199387\" id=\"outline-link-H16199387\">- Dextromethorphan testing</a></li></ul></li></ul></li><li><a href=\"#H24717885\" id=\"outline-link-H24717885\">DIAGNOSIS</a></li><li><a href=\"#H16\" id=\"outline-link-H16\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">ADDITIONAL RESOURCES</a></li><li><a href=\"#H275830261\" id=\"outline-link-H275830261\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H22\" id=\"outline-link-H22\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"EM/6488|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=EM/83590\" class=\"graphic graphic_figure\">- Acetaminophen poisoning nomogram</a></li></ul></li><li><div id=\"EM/6488|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=EM/66199\" class=\"graphic graphic_table\">- Dextromethorphan-DXM street names</a></li><li><a href=\"image.htm?imageKey=EM/64604\" class=\"graphic graphic_table\">- Serotonin syndrome drugs</a></li><li><a href=\"image.htm?imageKey=EM/94240\" class=\"graphic graphic_table\">- Common ingredients cough and cold medications</a></li><li><a href=\"image.htm?imageKey=EM/71268\" class=\"graphic graphic_table\">- Common poisoning syndromes - toxidromes</a></li><li><a href=\"image.htm?imageKey=EM/52785\" class=\"graphic graphic_table\">- Organic psychosis</a></li><li><a href=\"image.htm?imageKey=EM/50275\" class=\"graphic graphic_table\">- Drug psychosis</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acetaminophen-paracetamol-poisoning-in-adults-pathophysiology-presentation-and-diagnosis\" class=\"medical medical_review\">Acetaminophen (paracetamol) poisoning in adults: Pathophysiology, presentation, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=anticholinergic-poisoning\" class=\"medical medical_review\">Anticholinergic poisoning</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-child-with-occult-toxic-exposure\" class=\"medical medical_review\">Approach to the child with occult toxic exposure</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=carbamazepine-poisoning\" class=\"medical medical_review\">Carbamazepine poisoning</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acetaminophen-paracetamol-poisoning-in-children-and-adolescents\" class=\"medical medical_review\">Clinical manifestations and diagnosis of acetaminophen (paracetamol) poisoning in children and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-rhabdomyolysis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of rhabdomyolysis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dextromethorphan-poisoning-treatment\" class=\"medical medical_review\">Dextromethorphan poisoning: Treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=emergency-department-evaluation-of-acute-onset-psychosis-in-children\" class=\"medical medical_review\">Emergency department evaluation of acute onset psychosis in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=ethanol-intoxication-in-adults\" class=\"medical medical_review\">Ethanol intoxication in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=ethanol-intoxication-in-children-clinical-features-evaluation-and-management\" class=\"medical medical_review\">Ethanol intoxication in children: Clinical features, evaluation, and management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-and-management-of-adult-and-adolescent-sexual-assault-victims\" class=\"medical medical_review\">Evaluation and management of adult and adolescent sexual assault victims</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-of-stupor-and-coma-in-children\" class=\"medical medical_review\">Evaluation of stupor and coma in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=intoxication-from-lsd-and-other-common-hallucinogens\" class=\"medical medical_review\">Intoxication from LSD and other common hallucinogens</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=ketamine-poisoning\" class=\"medical medical_review\">Ketamine poisoning</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=lithium-poisoning\" class=\"medical medical_review\">Lithium poisoning</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-acetaminophen-paracetamol-poisoning-in-children-and-adolescents\" class=\"medical medical_review\">Management of acetaminophen (paracetamol) poisoning in children and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-moderate-and-severe-alcohol-withdrawal-syndromes\" class=\"medical medical_review\">Management of moderate and severe alcohol withdrawal syndromes</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=over-the-counter-cough-and-cold-preparations-approach-to-pediatric-poisoning\" class=\"medical medical_review\">Over-the-counter cough and cold preparations: Approach to pediatric poisoning</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=phencyclidine-pcp-intoxication-in-adults\" class=\"medical medical_review\">Phencyclidine (PCP) intoxication in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=phencyclidine-pcp-intoxication-in-children-and-adolescents\" class=\"medical medical_review\">Phencyclidine (PCP) intoxication in children and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=phenylephrine-and-related-decongestants-pediatric-poisoning\" class=\"medical medical_review\">Phenylephrine and related decongestants: Pediatric poisoning</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=phenytoin-poisoning\" class=\"medical medical_review\">Phenytoin poisoning</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=salicylate-aspirin-poisoning-in-adults\" class=\"medical medical_review\">Salicylate (aspirin) poisoning in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=salicylate-poisoning-in-children-and-adolescents\" class=\"medical medical_review\">Salicylate poisoning in children and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=serotonin-syndrome-serotonin-toxicity\" class=\"medical medical_review\">Serotonin syndrome (serotonin toxicity)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-general-measures-for-acute-poisoning-treatment\" class=\"medical medical_society_guidelines\">Society guideline links: General measures for acute poisoning treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-treatment-of-acute-poisoning-caused-by-specific-agents-other-than-drugs-of-abuse\" class=\"medical medical_society_guidelines\">Society guideline links: Treatment of acute poisoning caused by specific agents other than drugs of abuse</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=testing-for-drugs-of-abuse-doa\" class=\"medical medical_review\">Testing for drugs of abuse (DOA)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=trauma-management-approach-to-the-unstable-child\" class=\"medical medical_review\">Trauma management: Approach to the unstable child</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=wernicke-encephalopathy\" class=\"medical medical_review\">Wernicke encephalopathy</a></li></ul></div></div>","javascript":null}